Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oxbridge Clinical
Cambridge, United Kingdomoxbridgeclinical.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Oxbridge Clinical is developing a point-of-care diagnostic device using solid-state nanopores to rapidly and quantitatively detect over 50 viruses, bacteria, and fungi from various sample types. The technology aims to enable fast (<15 min), affordable (<$50/test), and comprehensive etiological diagnosis of respiratory infections at the point of care. This approach is designed to reduce inappropriate antibiotic use by distinguishing between viral and bacterial causes of infection.
- Therapeutic areas
- Infectious Diseases
- Modalities
- DeviceDiagnostic technology (solid-state nanopore-based)
- Industry
- Molecular Diagnostics
02
Partnerships
Not specified in available sources.
Beyond the preview
Go deeper on Oxbridge Clinical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Oxbridge Clinical.